Skip to main content

New and competing renewal awards for February 2018

Friday, March 16, 2018
McGovern-Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of February 2018. Please extend your congratulations to the following individuals.

Salim Idriss (Cardiology) has received an award from Medtronic in the amount of $15,000 for a project entitled, “Medtronic Duke Pediatric Electrophysiology Fellowship”.  The project period is 07/01/2018 – 06/30/2019.

Monica Lemmon (Neurology) has received an award from the University of Michigan/Pediatric Epilepsy Research Foundation in the amount of $9,000 for a project entitled, “Spasm Prediction after Symptomatic Neonatal Seizures – the SPASM Study”.  The project period is 09/01/2017 – 08/31/2019.

Matthew Kelly (Infectious Diseases) has received an award from the ARLG Early Stage Investigator (ESI) Seed Grant in the amount of $50,000 for a project entitled, “The Acquisition and Persistence of Antibiotic Resistance Genes in a High-Risk Pediatric Population”.  The project period is 12/01/2017 – 11/30/2018.

Baodong Sun (Medical Genetics) has received an award from Alnylam Pharmaceuticals Inc. in the amount of $106,875 for a project entitled “Liver-specific knockdown of M6PR with RNAi therapeutics to increase enzyme delivery to muscle tissues of Pompe disease mice during ERT”.  The project period is 01/01/2018-09/30/2018.

Muhammad Zafar (Neurology) has received an award from Eisai Inc. in the amount of $62,957 for a project entitled” A retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients with Epilepsy”.  The project period is 01/30/2018-11/30/2019.

Mai Elmallah (Pulmonary and Sleep Medicine) has received an award from Savara Pharmaceuticals in the amount of $188,937 for a project entitled “A phase III randomized, double-blind, placebo-controlled study of Aero Vanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients”.  The project period is 11/20/2017-12/31/2019.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health